Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001171843-18-005616
Filing Date
2018-08-01
Accepted
2018-08-01 16:02:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 f424b5_072118.htm 424B5 576310
2 GRAPHIC logo.jpg GRAPHIC 2966
3 GRAPHIC logo2.jpg GRAPHIC 73676
  Complete submission text file 0001171843-18-005616.txt   683044
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221421 | Film No.: 18984710
SIC: 2836 Biological Products, (No Diagnostic Substances)